Effect of CD34+ selection and various schedules of stem cell reinfusion and granulocyte colony-stimulating factor priming on hematopoietic recovery after high-dose chemotherapy for breast cancer

Blood

Volumn 89, Issue 5, 1997, Pages 1521-1528

  Somlo, G ^a   Sniecinski, I ^b   Odom Maryon, T ^b   Nowicki, B ^b   Chow, W ^b   Hamasaki, V ^b   Leong, L ^b   Margolin, K ^b   Morgan Jr , R ^b   Raschko, J ^b   Shibata, S ^b   Tetef, M ^b   Molina, A ^b   Berenson, R J ^b   Forman, S J ^b   Doroshow, J H ^b  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; BONE MARROW METASTASIS; BONE MARROW PURGING; BONE MARROW RESCUE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CELL PROLIFERATION; CLINICAL ARTICLE; DRUG MEGADOSE; FEMALE; GROWTH STIMULATION; HEMATOPOIETIC STEM CELL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKAPHERESIS; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 0031036885     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.5.1521.1521_1521_1528     Document Type: Article

References (45)

1. Peters WP, Shpall EJ, Jones RB, Ross M: High-dose combination cyclophosphamide, cisplatin and carmustine with bone marrow support as initial treatment for metastatic breast cancer: Three-six year follow-up. Proc Am Soc Clin Oncol 9:10, 1990 (abstr 31)
2. Jones RB, Shpall EJ, Ross M, Bast R, Affronti M, Peters WP: AFM induction chemotherapy followed by intensive alkylating agent consolidation with autologous bone marrow support (ABMS) for advanced breast cancer: Current results. Proc Am Soc Clin Oncol 9:9, 1990 (abstr 30)
3. Dunphy FR, Spitzer G, Buzdar AU, Hortobagyi GN, Horwitz LJ, Yau JC, Spinolo JA, Jagannath S, Holmes F, Wallerstein RO, Bohannan PA, Dicke KA: Treatment of estrogen receptor-negative or hormonally refractory breast cancer with double high-dose chemotherapy intensification and bone marrow support. J Clin Oncol 8:1207, 1990
4. Williams SF, Mick R, Desser R, Golick J, Beschorner J, Bitran JD: High-dose consolidation therapy with autologous stem cell rescue in stage IV breast cancer. J Clin Oncol 7:1824, 1989
5. Doroshow JH, Somlo G, Ahn C, Baker P, Rincon A, Forman S, Akman S, Chow W, Coluzzi P, Hamasaki V, Leong L, Margolin K, Molina A, Morgan R, Raschko J, Shibata S, Tetef M, Yen Y, Brent J: Prognostic factors predicting progression-free and overall survival in patients with responsive metastatic breast cancer treated with high-dose chemotherapy and bone marrow stem cell reinfusion. Proc Am Soc Clin Oncol 14:319, 1995 (abstr 942)
6. Peters W, Ross M, Vredenburgh J, Meisenberg B, Marks LB, Winer E, Kurtzberg J, Bast RC, Jones R, Shpall E, Wu K, Rosner G, Gilbert C, Mathias B, Coniglio D, Petros W, Henderson IC, Norton L, Weiss RB, Budman D, Hurd D: High-dose chemotherapy and autologous bone marrow support as consolidation after standarddose adjuvant therapy for high risk primary breast cancer. J Clin Oncol 11:1132, 1993
7. Gianni AM, Siena S, Bregni M, Nicola D, Dodero A, Zambetti M, Orefice S, Salvadori B, Luini A, Greco M, Zucali R, Valagussa P, Bonadonna G: 5-year results of high-dose sequential (HDS) adjuvant chemotherapy in breast cancer with ≥10 positive nodes. Proc Am Soc Clin Oncol 14:90, 1995 (abstr 61)
8. Somlo G, Doroshow J, Forman S, Ahn C, Leong L, Margolin K, Morgan R, Raschko J, Brent J, Baker P, Rincon A, Chow W, Akman S, Shibata S, Tetef M, Coluzzi P, Molina A, Niland J, Stein A, Smith E, Yen Y: High-dose chemotherapy and stem cell rescue for the treatment of primary high-risk breast cancer: Prognostic indicators of overall survival and progression-free survival. Proc Am Soc Clin Oncol 14:113, 1995 (abstr 150)
9. Peters WP, Shpall EJ, Jones RB, Olsen GA, Bast RC, Gockerman JP, Moore JO: High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer. J Clin Oncol 6:1368, 1988
10. Antman K, Ayash L, Elias A, Wheeler C, Hunt M, Eder JP, Teicher BA, Critchlow J, Bibbo J, Schnipper LE, Frei E: A Phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose chemotherapy. J Clin Oncol 10:102, 1992
11. Kennedy MJ, Beveridge RA, Rowley SD, Gordon GB, Abeloff MD, Davidson NE: High-dose chemotherapy with reinfusion of purged autologous bone marrow following dose-intense induction as initial therapy for metastatic breast cancer. J Natl Cancer Inst 83:920, 1991
12. Ayash LJ, Elias A, Wheeler C, Reich E, Schwartz G, Mazanet R, Tepler I, Warren D, Lynch C, Gonin R, Schnipper L, Frei E, Antman K: Double dose-intensive chemotherapy with autologous marrow and peripheral-blood progenitor-cell support for metastatic breast cancer: A feasibility study. J Clin Oncol 12:37, 1994
13. Kessinger A, Armitage JO: The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies. Blood 22:211, 1991
14. Sheridan WP, Begley CG, Juttner C, Szer J, To LB, Maher D, McGrath KM, Morstyn G, Fox RM: Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 339:640, 1992
15. Brugger W, Birken R, Bertz H, Hecht T, Pressler K, Frisch J, Schulz G, Mertelsmann R, Kanz L: Peripheral blood progenitor cells mobilized by chemotherapy plus granulocyte-colony stimulating factor accelerate both neutrophil and platelet recovery after high-dose VP16, ifosfamide and cisplatin. Br J Haematol 84:402, 1993
16. Nademanee A, Sniecinski I, Schmidt GM, Dagis AC, O'Donnell MR, Snyder DS, Parker PM, Stein AS, Smith EP, Molina A, Stepan DE, Somlo G, Margolin KA, Woo D, Niland JC, Forman SJ: High-dose chemotherapy followed by autologous peripheral blood transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and colony-stimulating factor-mobilized peripheral-blood stem cells. J Clin Oncol 12:2176, 1994
17. Cote RJ, Rosen PP, Lesser ML, Old LJ, Osborne MP: Predication of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J Clin Oncol 9:1749, 1991
18. Diel IJ, Kaufman M, Goerner R, Costa SD, Kaul S, Bastert G. Detection of tumor cells in bone marrow of patients with primary breast cancer: a prognostic factor for distant metastasis. J Clin Oncol 10:1749, 1941
19. Ross AA, Cooper BW, Lazarus HM, Mackay W, Moss TJ, Ciobanu N, Tallman MS, Kennedy MJ, Davidson NE, Sweet D, Winter C, Akrad L, Jansen J, Copelan E, Meagher RC, Herzig RH, Klumpoo TR, Kahn DG, Warner NE: Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. Blood 82:2605, 1993
20. Shpall EJ, Bast RC Jr, Joines WT, Jone RB, Anderson I, Johnson C, Eggleston S, Tepperberg M, Edwards S, Peters WP: Immunomagnetic purging of breast cancer from bone marrow for autologous transplantation. Bone Marrow Transplant 7:145, 1991
21. Shpall EJ, Jones RB, Bast RC Jr, Rosner GL, Vandermark R, Ross M, Afronti ML, Johnson C, Eggleston S, Tepperburg M, Coniglio D, Peters WP: 4-hydroperoxycyclophosphamide purging of breast cancer from the mononuclear cell fraction of bone marrow in patients receiving high-dose chemotherapy and autologous marrow support: A phase I trial. J Clin Oncol 9:85, 1991
22. Shpall EJ, Jones RB, Bearman SI, Franklin WA, Archer PG, Curiel T, Bitter M, Claman HN, Stemmer S, Purdy M, Myers SE, Hami L, Taffs S, Heimfeld S, Hallagan J, Berenson RJ: Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: Influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J Clin Oncol 12:28, 1994
23. + cells to remove circulating tumor cells. Blood 87:1625, 1996
24. + peripheral blood progenitor cells after high dose chemotherapy for patients with advanced multiple myeloma. Blood 86:397, 1995
25. Somlo G, Doroshow JH, Forman SJ, Leong LA, Margolin KA, Morgan RJ, Raschko JW, Akman SA, Ahn C, Nagasawa S, Harrison J: High-dose doxorubicin, etoposide, and cyclophosphamide with stem cell reinfusion in patients with metastatic or high-risk primary breast cancer. Cancer 73:1678, 1994
26. Somlo G, Doroshow JH, Forman SJ, Leong LA, Margolin KA, Morgan RJ, Raschko JW, Akman SA, Ahn C, Sniecinski I: High-dose cisplatin, etoposide, and cyclophosphamide with autologous stem cell reinfusion in patients with responsive metastatic or high-risk primary breast cancer. Cancer 73:125, 1994
27. Somlo G, Doroshow JH, Lev-Ran A, Ahn DC, Hwang L, Raschko JW, Forman SJ, Margolin KA, Morgan RJ, Leong LA, Hamasaki VK, Chow WA, Molina A, Ahmad B, Akman SA, Jojian A, Menard P: Effect of low-dose prophylactic dopamine on high-dose cisplatin-induced electrolyte wasting, ototoxicity, and epidermal growth factor excretion: A randomized, placebo-controlled, double-blind trial. J Clin Oncol 13:1231, 1995
28. Conover WJ, Iman RL: Rank transformations as a bridge between parametric and nonparametric statistics. The American Statistician 35:124, 1981
29. SAS Software. Cary, NC, SAS Institute Inc, 1981
30. + cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicin. Blood 84:1421, 1994
31. Bensinger W, Applebaum F, Rowley S, Storb R, Sanders J, Lilleby K, Gooley T, Demirer T, Schiffman K, Weaver C, Clift R, Chauncey T, Klarnet J, Montgomery P, Petersdorf S, Weiden P, Witherspoon R, Buckner CD: Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol 13:2547, 1995
32. Klumpp TR, Mangan KF, Goldberg SL, Pearlman ES, Macdonald JS: Granulocyte colony-stimulating factor accelerates neutrophil engraftment following peripheral-blood stem-cell transplantation: A prospective, randomized trial. J Clin Oncol 13:1323, 1995
33. + blood cells. Blood 86:2500, 1995
34. Watts MJ, Jones HM, Sullivan AM, Langaber SE, Jamieson E, Fielding A, Williams C, Berenson RJ, Goldstone AH, Linch DC: Accessory cells do not contribute to G-CSF or IL-6 production nor to rapid haematological recovery following peripheral blood stem cell transplantation. Br J Haematol 91:767, 1995
35. Linenberger ML, Beebe AM, Pedersen NC, Abkowitz JL, Dandekar S. Marrow accessory cell infection and alterations in hematopoiesis accompany severe neutropenia during experimental acute infection with feline immunodeficiency virus. Blood 85:941, 1995
36. Hananai EG, Kavanagh J, Giles RE, Kudelka A, Rahman Z, Holmes F, Hortobagyi G, Hamer J, Calvert L, Finnegan MB, Mante R, Ellerson D, Geisler D, Wang T, Su Y, Zu Z, Chen N, Berenson R, Heimfeld S, Claxton D, Mechetner E, Holzmayer T, Mehra R, Cote R, Champlin R, Deisseroth AB: Rapid neutrophil recovery in autologous transplants using cells that have been exposed to a multiple drug resistance (MDR-1) retroviral vector. Blood 86:462a, 1995 (abstr 1833)
37. Brenner MK, Rill DR, Moen RC, Krance RA, Mirro J Jr, Anderson WF, Ihle JN: Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 341:85, 1993
38. Deisseroth A, Zu Z, Claxton D, Hanania EG, Fu S, Ellerson D, Goldberg L, Thomas M, Janicek K, Anderson WF, Hester J, Korbling M, Durett A, Moen R, Berenson R, Heimfeld S, Hamer J, Calvert L, Tibbits P, Talpaz M, Kantarjian H, Champlin R, Reading C: Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood 83:3068, 1994
39. Vredenburgh JJ, Shpall EJ, Ross M, Meisenberg B, Bast R, Tyer C, Tepperberg M, Eggleston S, Peters WP: Immunopharmacologic bone marrow purging and high dose chemotherapy with autologous bone marrow support (ABMS) for patients with metastatic breast cancer. Proc Am Soc Clin Oncol 11:58, 1992 (abstr 58)
40. Tyer CL, Vredenburgh JJ, Heimer M, Peters WP, Bast Jr RC: Breast cancer cells are effectively purged from peripheral blood progenitor cells with an immunomagnetic technique. Clin Cancer Res 2:81, 1996
41. Brugger W, Heimfeld S, Berenson RJ, Mertelsmann R, Kanz L: Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. N Engl J Med 333:283, 1995
42. Bensinger WI, Weaver CH, Appelbaum FR, Rowly S, Demirer T, Sanders J, Storb R, Buckner CD: Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 85:1655, 1995
43. Kastan M, Schlaffer E, Russo J, Colvin O, Civin C, Hilton J: Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells. Blood 75:1947, 1990
44. Chaudhary P, Roninson IB: Expression and activity of Pglycoprotein, a multidrug effux pump, in human hematopoietic stem cells. Cell 65:85, 1991
45. Geissler K, Koller E, Hinterberger W, Niederwieser D, Knobl P, Pabinger I, Werner D, Scherrer R, Schwarzinger I, Friedl J, Jaeger U, Lechner K: Concomitant administration of granulocyte colony-stimulating factor (G-CSF) and induction chemotherapy of adult acute lymphoblastic leukemia (ALL)-First results of a multicenter, open-label, Phase III study in randomized parallel groups (meeting abstract). Blood 84:231a, 1994 (abstr, suppl 1)